Abcam PLC ADR Logo
US0003802040
ABCM

Abcam PLC ADR

Loading quotes...

Forecast

Buy
  1
Hold
  4
Sell
  0

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2025, Abcam PLC ADR has already paid €0.84 in dividends. The last payout was in September 2025.

Financials

In the last year, Abcam PLC ADR had revenue of €407.94m and net profit of -€9.59m
(EUR) 2022
YoY
Revenue 407.94m 27.29%
Gross profit 305.08m 16.21%
Net profit -9.59m 145.98%
EBITDA 48.16m 60.88%

Fundamentals

Metric Value
Market capitalization
€5.01bn
Number of shares
230.15m
52-week high/low
€22.96 - €11.32
Dividends No
Beta
0.86
P/E ratio
578.30
PEG ratio
5.78
P/B ratio
3.88
P/S ratio
0.00

Company profile

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Name
Abcam PLC ADR
CEO
Alan Thomas Hirzel BS,
Headquarters Cambridge,
United Kingdom
Website
Sector
Consumer Staples
Industry
Food Products
IPO
22/10/2020
Employees 1,760

Ticker symbols

Exchange Symbol
NASDAQ
ABCM
🍪

Parqet  uses cookies. Learn more